Search results
Shareholders have faith in loss-making Janux Therapeutics (NASDAQ:JANX) as stock climbs 20% in past...
Simply Wall St. via Yahoo Finance· 1 year agoWhile Janux Therapeutics, Inc. (NASDAQ:JANX) shareholders are probably generally happy, the stock...
Marker Therapeutics (NASDAQ:MRKR) hikes 26% this week, taking one-year gains to 95%
Simply Wall St. via Yahoo Finance· 11 months agoThese days it's easy to simply buy an index fund, and your returns should (roughly) match the...
Zacks Industry Outlook Highlights United Therapeutics, Esperion Therapeutics., Heron Therapeutics,...
Zacks via Yahoo Finance· 4 months agoUnited Therapeutics, Esperion Therapeutics., Heron Therapeutics, Lyra Therapeutics and Aldeyra...
Lyra (LYRA) Posts Upbeat Data on Rhinosinusitis Study, Stock Up
Zacks via Yahoo Finance· 9 months agoLyra Therapeutics LYRA reported positive data from the ongoing phase II BEACON study, evaluating...
Akero (AKRO) Up on Upbeat Week 96 Data From Liver Disease Study
Zacks via Yahoo Finance· 4 months agoAkero (AKRO) reports positive results from its mid-stage study of efruxifermin in pre-cirrhotic...
Lyra Therapeutics Inc (LYRA) Posts Year-End Financial Results, Aligns with EPS Projections
GuruFocus.com via Yahoo Finance· 3 months agoEstimated Earnings Per Share: Analysts projected -$0.2775, LYRA reported a full year EPS of -$1.26. Estimated Net Income: Analysts estimated a net loss of -$15.335 million for the quarter, LYRA ...
Arkansas medical marijuana sales up in July
Ft. Smith Southwest Times Record via Yahoo News· 2 years agoMedical marijuana patients spent $23.3 million in July at the state’s 38 dispensaries to take home 4,171 pounds. Natural Relief Dispensary of Sherwood...
Medical marijuana generates October revenue for state
Ft. Smith Southwest Times Record via Yahoo News· 2 years agoRecreational marijuana may have failed at the polls this month, but sales of medical marijuana in...
Candel Therapeutics Inc (CADL) Reports Q3 2023 Financial Results and Clinical Progress
GuruFocus.com via Yahoo Finance· 8 months agoCandel Therapeutics Inc (NASDAQ:CADL) announces Q3 2023 results with promising clinical data and a solid cash position. Significant clinical milestones achieved in the development of CAN-2409 ...
Letters to the Editor: Why the COVID mask debate feels unsettlingly different now
Los Angeles Times Opinion via Yahoo News· 2 years agoAmid a COVID surge fueled by the hyper-infectious BA.5 subvariant, masked and unmasked shoppers walk...